Close Menu
    National News Brief
    Wednesday, November 18
    • Home
    • Business
    • Lifestyle
    • Science
    • Technology
    • International
    • Arts & Entertainment
    • Sports
    National News Brief
    Home » White House drops Heidi Overton’s FDA nomination for commissioner

    White House drops Heidi Overton’s FDA nomination for commissioner

    Team_NationalNewsBriefBy Team_NationalNewsBriefNovember 18, 2026 International No Comments3 Mins Read
    Share
    Facebook Twitter LinkedIn Pinterest Email

    WASHINGTON — The White House is dropping Dr. Heidi Overton’s nomination to lead the Food and Drug Administration, a White House official confirmed Tuesday.

    The decision comes a day before the Senate Health Committee was scheduled to vote on whether to advance her nomination to the full Senate for confirmation.

    Axios first reported the White House’s decision.

    The move follows weeks of doubts from key Republicans on the Health, Education, Pensions and Labor Committee. To advance to the full Senate, Overton would have needed 11 votes in the 21-member committee, meaning she couldn’t afford to lose a single Republican if all Democrats opposed her.

    Sen. Bill Cassidy of Louisiana, the committee’s chairman, questioned whether Overton — a preventive medicine doctor who serves as a domestic policy official in the White House — had enough experience to lead the agency.

    Before Overton’s confirmation hearing in September, Cassidy wrote on X that he had “strong concerns” about her nomination, saying her lack of managerial experience left her poorly prepared to lead the agency. In a post last week, Cassidy said he remained undecided.

    Prior to joining the White House, Overton worked as chief policy officer at the conservative think tank America First Policy Institute.

    Sen. Susan Collins, R-Maine, told NBC News last week that she was undecided and had “not taken a position,” saying she needed “to get some answers on various things.”

    Sen. Lisa Murkowski of Alaska declined last week to say how she’d vote. During the confirmation hearing, Murkowski asked Overton about political pressure surrounding access to mifepristone, and criticized Overton for not taking a clear position on the subject.

    Overton has praised the Supreme Court’s decision to overturn Roe v. Wade and called for strict restrictions on medication abortion.

    The FDA is set to finish its safety review of mifepristone in March, one of the most consequential decisions the agency faces.

    Overton’s nomination was already working against a tight window. Democrats take control of the Senate in January, when she would have to be renominated, and her chances of being confirmed then would be slim.

    The FDA has been without a permanent commissioner since Dr. Marty Makary resigned in May, in part because of the administration’s decision to authorize several fruit-flavored vaping products.

    The vacancy adds to a long period of upheaval at the nation’s top health agencies.

    The Centers for Disease Control and Prevention went nearly a year without a permanent director after Health Secretary Robert F. Kennedy Jr. removed Susan Monarez just 29 days into the job last year. Trump’s first pick for that role, former congressman Dave Weldon, couldn’t secure enough Republican support, and the agency cycled through a series of acting leaders before the Senate confirmed Dr. Erica Schwartz in August.



    Source link

    Team_NationalNewsBrief
    • Website

    Keep Reading

    Is It Worth the Price?

    Jensen Huang agrees to House interview on Nvidia’s sales to China

    Putin’s Kerch Bridge to Crimea partially destroyed by Ukraine strike

    California lifeguard recalls braving relentless waves in rescue caught on video

    U.S. loses measles-elimination status, erasing decades of progress

    Outages impact Chase banking online and at some branches

    Add A Comment

    Comments are closed.

    Editors Picks

    EU Not Included in New G5

    December 14, 2025

    Israel carrying out ‘live-streamed genocide’ in Gaza, Amnesty says | Israel-Palestine conflict News

    April 29, 2025

    Trump says he’ll decide whether to livestream the execution of Fort Hood shooter Nidal Hasan

    October 10, 2026

    Sam Altman backs Anthropic CEO’s call to slow down the global AI race

    September 12, 2026

    Death toll surpasses 1,000 in Lebanon as Israeli bombardment continues | Israel attacks Lebanon News

    March 19, 2026
    Categories
    • Arts & Entertainment
    • Business
    • International
    • Latest News
    • Lifestyle
    • Opinions
    • Politics
    • Science
    • Sports
    • Technology
    • Top Stories
    • Trending News
    • World Economy
    About us

    Welcome to National News Brief, your one-stop destination for staying informed on the latest developments from around the globe. Our mission is to provide readers with up-to-the-minute coverage across a wide range of topics, ensuring you never miss out on the stories that matter most.

    At National News Brief, we cover World News, delivering accurate and insightful reports on global events and issues shaping the future. Our Tech News section keeps you informed about cutting-edge technologies, trends in AI, and innovations transforming industries. Stay ahead of the curve with updates on the World Economy, including financial markets, economic policies, and international trade.

    Editors Picks

    U.S. officially loses measles elimination status in a body blow to public health

    November 18, 2026

    White House drops Heidi Overton’s FDA nomination for commissioner

    November 18, 2026

    How Trump’s chip restrictions on South East Asia will hit China

    November 17, 2026

    Market Talk – November 17, 2026

    November 17, 2026
    Categories
    • Arts & Entertainment
    • Business
    • International
    • Latest News
    • Lifestyle
    • Opinions
    • Politics
    • Science
    • Sports
    • Technology
    • Top Stories
    • Trending News
    • World Economy
    • Privacy Policy
    • Disclaimer
    • Terms and Conditions
    • About us
    • Contact us
    Copyright © 2024 Nationalnewsbrief.com All Rights Reserved.

    Type above and press Enter to search. Press Esc to cancel.